FDA Approved: ARESTIN — Supplemental Application (OraPharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ARESTIN (minocycline hydrochloride) submitted by OraPharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• ARESTIN (MINOCYCLINE HYDROCHLORIDE)

Snippet

SUPPL AP for ARESTIN (MINOCYCLINE HYDROCHLORIDE)